| scholarly article | Q13442814 |
| P2093 | author name string | Meng Chen | |
| Christopher G Wood | |||
| Pheroze Tamboli | |||
| Xifeng Wu | |||
| Yuanqing Ye | |||
| Surena Matin | |||
| Hushan Yang | |||
| Jian Gu | |||
| Nizar M Tannir | |||
| P2860 | cites work | The RBCC gene RFP2 (Leu5) encodes a novel transmembrane E3 ubiquitin ligase involved in ERAD | Q24297892 |
| Telomere measurement by quantitative PCR | Q24529938 | ||
| Cancer statistics, 2008 | Q27860585 | ||
| A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer | Q28303909 | ||
| Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1 | Q28943480 | ||
| Genome-wide association study of prostate cancer identifies a second risk locus at 8q24 | Q29614925 | ||
| A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25 | Q29614944 | ||
| Increasing incidence of all stages of kidney cancer in the last 2 decades in the United States: an analysis of surveillance, epidemiology and end results program data | Q30666907 | ||
| High telomerase activity correlates with the stabilities of genome and DNA ploidy in renal cell carcinoma | Q30827424 | ||
| Consistent chromosome 3p deletion and loss of heterozygosity in renal cell carcinoma | Q33557607 | ||
| Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma. | Q33863055 | ||
| Role of chromosome 3p12-p21 tumour suppressor genes in clear cell renal cell carcinoma: analysis of VHL dependent and VHL independent pathways of tumorigenesis | Q33918504 | ||
| p62 overexpression in breast tumors and regulation by prostate-derived Ets factor in breast cancer cells | Q34191255 | ||
| Whole genome SNP arrays as a potential diagnostic tool for the detection of characteristic chromosomal aberrations in renal epithelial tumors. | Q34745214 | ||
| High-resolution genomic profiling of chromosomal aberrations using Infinium whole-genome genotyping | Q35012994 | ||
| Laparoscopic radical nephrectomy and minimally invasive surgery for kidney cancer | Q35598251 | ||
| CDKNA2A mutation analysis, protein expression, and deletion mapping of chromosome 9p in conventional clear-cell renal carcinomas: evidence for a second tumor suppressor gene proximal to CDKN2A. | Q35746241 | ||
| Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy. | Q36119612 | ||
| The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis | Q36313089 | ||
| Screening for copy-number alterations and loss of heterozygosity in chronic lymphocytic leukemia--a comparative study of four differently designed, high resolution microarray platforms | Q81290124 | ||
| Comparative study of renal cell carcinoma by CGH, multicolor-FISH and conventional cytogenic banding analysis | Q81323668 | ||
| Loss of heterozygosity at chromosome 14q is associated with poor prognosis in head and neck squamous cell carcinomas | Q81390253 | ||
| High-resolution analysis of DNA copy number alterations and gene expression in renal clear cell carcinoma | Q81409194 | ||
| Identification of copy number alterations and its association with pathological features in clear cell and papillary RCC | Q81746525 | ||
| Genome-wide screening of copy number alterations and LOH events in renal cell carcinomas and integration with gene expression profile | Q36477174 | ||
| Telomeres and chromosome instability | Q36511481 | ||
| Telomere shortening and mitotic dysfunction generate cytogenetic heterogeneity in a subgroup of renal cell carcinomas | Q36695388 | ||
| Loss of heterozygosity and copy number abnormality in clear cell renal cell carcinoma discovered by high-density affymetrix 10K single nucleotide polymorphism mapping array | Q36730935 | ||
| Prognostic factors in localized renal cell cancer | Q36794758 | ||
| Advanced renal cell carcinoma: current and emerging management strategies | Q36839658 | ||
| Prognostic factors and selection for clinical studies of patients with kidney cancer | Q36968662 | ||
| Telomere dysfunction, genome instability and cancer | Q36992359 | ||
| Comparison of DNA gains and losses in primary renal clear cell carcinomas and metastatic sites: importance of 1q and 3p copy number changes in metastatic events | Q38475708 | ||
| The correlation between the loss of chromosome 14q with histologic tumor grade, pathologic stage, and outcome of patients with nonpapillary renal cell carcinoma | Q38478491 | ||
| Patterns of aneuploidy in stage IV clear cell renal cell carcinoma revealed by comparative genomic hybridization and spectral karyotyping | Q38483900 | ||
| Amplification at 7q22 targets cyclin-dependent kinase 6 in T-cell lymphoma | Q40054898 | ||
| High-resolution analysis of chromosome rearrangements on 8p in breast, colon and pancreatic cancer reveals a complex pattern of loss, gain and translocation | Q40288019 | ||
| Cytosolic overexpression of p62 sequestosome 1 in neoplastic prostate tissue | Q40331818 | ||
| Molecular cytogenetic characterization shows higher genetic homogeneity in conventional renal cell carcinoma compared to other kidney cancers. | Q40514452 | ||
| Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL. | Q40633683 | ||
| PTEN/MMAC1/TEP1 mutations in human primary renal-cell carcinomas and renal carcinoma cell lines | Q40833639 | ||
| Differential susceptibility of renal carcinoma cell lines to tumor suppression by exogenous Fhit expression. | Q40874751 | ||
| Computer image analysis of comparative genomic hybridization. | Q41005524 | ||
| Genome-wide loss of heterozygosity and copy number analysis in melanoma using high-density single-nucleotide polymorphism arrays. | Q42806564 | ||
| Mutations of the VHL tumour suppressor gene in renal carcinoma | Q42806703 | ||
| Chromosome arm 8p and cancer: a fragile hypothesis. | Q44614687 | ||
| Cyclin-dependent kinase 6 (CDK6) amplification in human gliomas identified using two-dimensional separation of genomic DNA. | Q46006341 | ||
| High-resolution array-based comparative genomic hybridization of bladder cancers identifies mouse double minute 4 (MDM4) as an amplification target exclusive of MDM2 and TP53. | Q46091081 | ||
| Genetic aberrations detected by comparative genomic hybridization are associated with clinical outcome in renal cell carcinoma. | Q46525301 | ||
| Rising incidence of renal cell cancer in the United States | Q46854143 | ||
| Molecular cytogenetic analysis of 17 renal cancer cell lines: increased copy number at 5q31-33 in cell lines from nonpapillary carcinomas. | Q52828398 | ||
| Molecular dissection of the chromosome band 7q21 amplicon in gastroesophageal junction adenocarcinomas identifies cyclin-dependent kinase 6 at both genomic and protein expression levels. | Q53480780 | ||
| Common fragile sites. | Q53653269 | ||
| Amplification and overexpression of the MDM4 (MDMX) gene from 1q32 in a subset of malignant gliomas without TP53 mutation or MDM2 amplification. | Q55476278 | ||
| Loss of heterozygosity and methylation of p16 in renal cell carcinoma | Q58371735 | ||
| Correlations of allelic imbalance of chromosome 14 with adverse prognostic parameters in 148 renal cell carcinomas | Q59526228 | ||
| Allelic losses at chromosome 17p in human renal cell carcinoma are inversely related to allelic losses at chromosome 3p | Q67880816 | ||
| A detailed deletion mapping of the short arm of chromosome 3 in sporadic renal cell carcinoma | Q68311936 | ||
| Frequent loss of heterozygosity on chromosome 14 occurs in advanced colorectal carcinomas | Q70571548 | ||
| Allelic losses on chromosomes 14, 10, and 1 in atypical and malignant meningiomas: a genetic model of meningioma progression | Q71729173 | ||
| Novel suppressor loci on chromosome 14q in primary bladder cancer | Q71887248 | ||
| Telomeric associations and loss of telomeric DNA repeats in renal tumors | Q72076160 | ||
| Telomere shortening in renal cell carcinoma | Q72657631 | ||
| Telomerase activity and telomere lengths: alterations in renal cell carcinomas | Q73036516 | ||
| The allelic loss of chromosome 3p25 with c‐myc gain is related to the development of clear‐cell renal cell carcinoma | Q73267658 | ||
| Significance of chromosome arm 14q loss in nonpapillary renal cell carcinomas | Q73308028 | ||
| Loss of heterozygosity at chromosomes 8p, 9p, and 14q is associated with stage and grade of non-papillary renal cell carcinomas | Q73923938 | ||
| Loss of heterozygosity on the short arm of chromosome 3 in renal cancer | Q74260097 | ||
| Genomic imbalances in 61 renal cancers from the proximal tubulus detected by comparative genomic hybridization | Q74440655 | ||
| Analysis of kidney tumors by comparative genomic hybridization and conventional cytogenetics | Q78365640 | ||
| Loss of 14q31-q32.2 in renal cell carcinoma is associated with high malignancy grade and poor survival | Q80210654 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | single-nucleotide polymorphism | Q501128 |
| renal cell carcinoma | Q1164529 | ||
| P304 | page(s) | 2342-2348 | |
| P577 | publication date | 2009-11-01 | |
| P1433 | published in | International Journal of Cancer | Q332492 |
| P1476 | title | Genome-wide profiling of chromosomal alterations in renal cell carcinoma using high-density single nucleotide polymorphism arrays | |
| P478 | volume | 125 |
| Q36606040 | A validated tumorgraft model reveals activity of dovitinib against renal cell carcinoma |
| Q37356519 | Absence of loss of heterozygosity of BRCA1 in a renal tumor from a BRCA1 germline mutation carrier |
| Q34280223 | BAP1 loss defines a new class of renal cell carcinoma |
| Q38379487 | Beyond Mutations: Additional Mechanisms and Implications of SWI/SNF Complex Inactivation |
| Q35740959 | Chromosomal imbalances revealed in primary renal cell carcinomas by comparative genomic hybridization. |
| Q38612636 | Clinical utility of concurrent single-nucleotide polymorphism microarray on fresh tissue as a supplementary test in the diagnosis of renal epithelial neoplasms |
| Q54323035 | D9S168 microsatellite alteration predicts a poor prognosis in patients with clear cell renal cell carcinoma and correlates with the down-regulation of protein tyrosine phosphatase receptor delta. |
| Q60908659 | DNA methylation associates with survival in non-metastatic clear cell renal cell carcinoma |
| Q36084718 | Emerging molecular classification in renal cell carcinoma: implications for drug development |
| Q34449963 | Epidemiology and risk factors for kidney cancer |
| Q36045807 | Establishment and characterization of a highly immunogenic human renal carcinoma cell line |
| Q36445030 | Fluorescence in situ hybridization as adjunct to cytology improves the diagnosis and directs estimation of prognosis of malignant pleural effusions |
| Q26863402 | Frontiers in clinical and molecular diagnostics and staging of metastatic clear cell renal cell carcinoma |
| Q33709786 | Genetic characterization of Polish ccRCC patients: somatic mutation analysis of PBRM1, BAP1 and KDMC5, genomic SNP array analysis in tumor biopsy and preliminary results of chromosome aberrations analysis in plasma cell free DNA |
| Q38939134 | Genomic Copy Number Alterations in Renal Cell Carcinoma with Sarcomatoid Features |
| Q28728573 | Genomic copy number alterations in clear cell renal carcinoma: associations with case characteristics and mechanisms of VHL gene inactivation |
| Q41887166 | Histopathologic subtype-specific genomic profiles of renal cell carcinomas identified by high-resolution whole-genome single nucleotide polymorphism array analysis |
| Q38484441 | Identification and validation of dysregulated metabolic pathways in metastatic renal cell carcinoma |
| Q39704965 | Interplay between pVHL and mTORC1 pathways in clear-cell renal cell carcinoma. |
| Q34188267 | Iodothyronine deiodinases and cancer |
| Q33729097 | Molecular genetics of clear-cell renal cell carcinoma |
| Q35551949 | Multilevel-analysis identify a cis-expression quantitative trait locus associated with risk of renal cell carcinoma |
| Q36668449 | New cancer targets emerging from studies of the Von Hippel‐Lindau tumor suppressor protein |
| Q90609011 | Next Generation Sequencing in Renal Cell Carcinoma: Towards Precision Medicine |
| Q36597622 | Regulation of glucose metabolism by p62/SQSTM1 through HIF1α |
| Q92593624 | Relevance of arm somatic copy number alterations for oncologic outcomes and tumor immune microenvironment in clear cell renal cell carcinoma |
| Q34683293 | SCCRO3 (DCUN1D3) antagonizes the neddylation and oncogenic activity of SCCRO (DCUN1D1) |
| Q37542249 | SQSTM1 is a pathogenic target of 5q copy number gains in kidney cancer |
| Q34258285 | Single-cell exome sequencing reveals single-nucleotide mutation characteristics of a kidney tumor |
| Q35606411 | Specific genomic aberrations predict survival, but low mutation rate in cancer hot spots, in clear cell renal cell carcinoma |
| Q36367103 | Stratification of clear cell renal cell carcinoma (ccRCC) genomes by gene-directed copy number alteration (CNA) analysis |
| Q34637666 | Subtyping of renal cortical neoplasms in fine needle aspiration biopsies using a decision tree based on genomic alterations detected by fluorescence in situ hybridization |
| Q36107376 | Telomere diseases |
| Q37091301 | Telomere dynamics in mice and humans |
| Q26771844 | The structure and function of NKAIN2-a candidate tumor suppressor |
| Q26748991 | Thyroid Hormones as Renal Cell Cancer Regulators |
| Q64977645 | Whole-Exome Sequencing Identifies Somatic Mutations Associated With Mortality in Metastatic Clear Cell Kidney Carcinoma. |
Search more.